Company’s 36-month beta value is 1.99.Analysts have differing opinions on the stock, with 7 analysts rating it as a “buy,” 1 as “overweight,” 5 as “hold,” and 0 as “sell.”
The public float for RKLB is 409.12M, and currently, short sellers hold a 12.66% ratio of that floaft. The average trading volume of RKLB on February 24, 2025 was 20.72M shares.
RKLB) stock’s latest price update
Rocket Lab USA Inc (NASDAQ: RKLB) has experienced a decline in its stock price by -6.77 compared to its previous closing price of 25.26. However, the company has seen a fall of -16.78% in its stock price over the last five trading days. fool.com reported 2025-02-22 that Last year was a record for Rocket Lab USA (RKLB -6.77%), with significant milestones and achievements in the aerospace industry.
RKLB’s Market Performance
RKLB’s stock has fallen by -16.78% in the past week, with a monthly drop of -20.49% and a quarterly rise of 22.08%. The volatility ratio for the week is 9.05% while the volatility levels for the last 30 days are 8.41% for Rocket Lab USA Inc The simple moving average for the last 20 days is -16.07% for RKLB’s stock, with a simple moving average of 79.72% for the last 200 days.
Analysts’ Opinion of RKLB
Morgan Stanley, on the other hand, stated in their research note that they expect to see RKLB reach a price target of $6, previously predicting the price at $8. The rating they have provided for RKLB stocks is “Equal-Weight” according to the report published on July 15th, 2024.
RKLB Trading at -12.08% from the 50-Day Moving Average
After a stumble in the market that brought RKLB to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -29.36% of loss for the given period.
Volatility was left at 8.41%, however, over the last 30 days, the volatility rate increased by 9.05%, as shares sank -25.40% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -4.58% lower at present.
During the last 5 trading sessions, RKLB fell by -16.78%, which changed the moving average for the period of 200-days by +488.75% in comparison to the 20-day moving average, which settled at $28.06. In addition, Rocket Lab USA Inc saw -7.54% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at RKLB starting from Armagno Nina, who sale 10,000 shares at the price of $23.63 back on Dec 11 ’24. After this action, Armagno Nina now owns 132,294 shares of Rocket Lab USA Inc, valued at $236,345 using the latest closing price.
NINA ARMAGNO, the Director of Rocket Lab USA Inc, proposed sale 10,000 shares at $23.63 during a trade that took place back on Dec 11 ’24, which means that NINA ARMAGNO is holding shares at $236,345 based on the most recent closing price.
Stock Fundamentals for RKLB
Current profitability levels for the company are sitting at:
- -0.51 for the present operating margin
- 0.24 for the gross margin
The net margin for Rocket Lab USA Inc stands at -0.52. The total capital return value is set at -0.21. Equity return is now at value -37.45, with -17.91 for asset returns.
Based on Rocket Lab USA Inc (RKLB), the company’s capital structure generated 0.5 points at debt to capital in total, while cash flow to debt ratio is standing at -0.21. The debt to equity ratio resting at 1.01. The interest coverage ratio of the stock is -51.92.
Currently, EBITDA for the company is -148.78 million with net debt to EBITDA at -0.86. When we switch over and look at the enterprise to sales, we see a ratio of 32.72. The receivables turnover for the company is 4.38for trailing twelve months and the total asset turnover is 0.32. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.58.
Conclusion
In a nutshell, Rocket Lab USA Inc (RKLB) has experienced a mixed performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
